New Topical Roflumilast Data Presented at the European Academy of Dermatology and Venereology (EADV) Congress
WESTLAKE VILLAGE, Calif., Sept. 27, 2021 (GLOBE NEWSWIRE) — Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a late-stage…
Month: September 2021
Salarius Pharmaceuticals to Present at the Virtual Benzinga Healthcare Small Cap Conference
HOUSTON, Sept. 27, 2021 (GLOBE NEWSWIRE) — Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX), a clinical-stage biopharmaceutical…
Erasca is Named One of Fierce Biotech’s “Fierce 15” Biotechnology Companies of 2021
SAN DIEGO, Sept. 27, 2021 (GLOBE NEWSWIRE) — Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision…
AGTC to Present at the 2021 Cantor Fitzgerald Virtual Global Healthcare Conference
GAINESVILLE, Fla. and CAMBRIDGE, Mass., Sept. 27, 2021 (GLOBE NEWSWIRE) — Applied Genetic Technologies Corporation…
Rafael Pharmaceuticals Announces APOLLO613 Phase I/II Clinical Trial of CPI-613® (devimistat) in Combination with Hydroxychloroquine in Patients with Relapsed Clear Cell Sarcoma Begins Enrollment at City of Hope in Duarte, Calif.
CRANBURY, N.J., Sept. 27, 2021 (GLOBE NEWSWIRE) — Rafael Pharmaceuticals, Inc. (“Rafael” or the “Company”),…
Fierce Biotech names Tvardi Therapeutics as one of its “Fierce 15” Biotech Companies of 2021
HOUSTON, Sept. 27, 2021 (GLOBE NEWSWIRE) — Tvardi Therapeutics (“Tvardi”) today announced that Fierce Biotech…
Ensysce Biosciences Announces $15 Million Convertible Note Financing
SAN DIEGO, Sept. 27, 2021 (GLOBE NEWSWIRE) — Ensysce Biosciences, Inc. (“Ensysce” or the “Company”)…
Cidara Therapeutics to Present New Data for Rezafungin at IDWeek 2021
SAN DIEGO, Sept. 27, 2021 (GLOBE NEWSWIRE) — Cidara Therapeutics, Inc. (NASDAQ: CDTX), a biotechnology…
BetterLife Files Patent for TD-0148A for Treatment of Cluster Headaches and Related Disorders
VANCOUVER, British Columbia, Sept. 27, 2021 (GLOBE NEWSWIRE) — BetterLife Pharma Inc. (“BetterLife” or the…
Immunovant to Participate in Roivant R&D Day 2021
NEW YORK, Sept. 27, 2021 (GLOBE NEWSWIRE) — Immunovant, Inc. (Nasdaq: IMVT), a clinical-stage biopharmaceutical…
Phathom Pharmaceuticals Announces Results from VONO-103, a Phase 1 Study Evaluating Gastric Acid Inhibition of Vonoprazan and Lansoprazole (PREVACID®)
Vonoprazan 20 mg demonstrated significantly greater acid suppressive effects over the 7-day study period compared…
SeqLL Announces Publication of a New Blood-Based RNA Sequencing Method to Detect Coronary Artery Disease
GW-Led Research uses SeqLL’s tSMS® platform to identify novel signature for detection of coronary artery…
Fierce Biotech names Ring Therapeutics as one of its “Fierce 15” Biotech Companies of 2021
CAMBRIDGE, Mass., Sept. 27, 2021 (GLOBE NEWSWIRE) — Ring Therapeutics today announced that Fierce Biotech…
Athenex Announces Phased European Launch of Klisyri® (tirbanibulin) for the Treatment of Actinic Keratosis
Klisyri has been approved for the treatment of actinic keratosis by the UK Medicines and…
Intrado Digital Media Announces Rebrand to Notified
ISLANDIA, N.Y., Sept. 27, 2021 (GLOBE NEWSWIRE) — Intrado Corporation (“Intrado”), a global leader in technology-enabled…
Verizon Business Unleashes the Next Generation of BlueJeans for the Future of Collaboration
What you need to know: Introducing BlueJeans Spaces and Collaboration Board; updates to Meetings and…
BlueJeans by Verizon Sets a New Bar for Workplace Flexibility, Virtual Engagement at Scale
What you need to know: Advancing hybrid-readiness, BlueJeans by Verizon announces cross-platform updates: BlueJeans Spaces…
Melissa Increases Sales and Support for China Business
Growing Asia Pacific focus reflects foundational nature of address management in global business operations and…
Spine Wave Announces the Commercial Launch of the Salvo® 5.5/6.0mm Spine System
SHELTON, Conn., Sept. 27, 2021 (GLOBE NEWSWIRE) — Spine Wave is pleased to announce the…
Logiq Initiates Major Restructuring Designed to Expand DataLogiq Business Unit and Unlock Value of Emerging Markets Initiatives
NEW YORK, Sept. 27, 2021 (GLOBE NEWSWIRE) — Logiq, Inc. (NEO: LGIQ) (OTCQX: LGIQ), a…